Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lucas Fernando Uratani"'
Autor:
Karina Costa Maia Vianna, Sérgio Lunardon Padilha, Bianca Ramos Ferronatto, Lucas Fernando Uratani, Felipe Augusto Santiago de Almeida, José Zanis Neto
Publikováno v:
Revista Brasileira de Cancerologia, Vol 58, Iss 1 (2012)
Introdução: Tumores estromais gastrointestinais (GIST) são neoplasias raras que se originam das células intersticiais de Cajal. Objetivo: Descrever a experiência do Hospital de Clínicas de Curitiba no tratamento do GIST localizado e avançado,
Externí odkaz:
https://doaj.org/article/bc8210d26f6d4304ae9d9edc64f2f09d
Autor:
Leonardo G Fonseca, Lucas Fernando Uratani, Gabriella Fernandes Soares, Paulo Siqueira Amaral, Regiane Saraiva Souza Melo Alencar, Aline Lopes Chagas, Venancio Avancini Ferreira Alves, Flair Jose Carrilho
Publikováno v:
Molecular and Clinical Oncology. 18
Background: The search for prognostic markers in hepatocellular carcinoma (HCC) is essential for clinical decisions. In addition to established variables such as liver function and tumor extent, cancer-associated inflammation can impact clinical outc
Autor:
Renata Colombo Bonadio, Laura Testa, Lucas Fernando Uratani, Pedro H. Hashizume, Francesco Sansone Bermejo
Publikováno v:
Cancer Research. 81:PS13-49
Background: Platinum-based chemotherapy (CT) regimens have activity in triple-negative breast cancer (TNBC), with overall response rates around 50%. The evidence for activity of these regimens for hormone receptor (HR)-positive breast cancer is scarc
Autor:
Joao Glasberg, Tiago Kenji Takahashi, Jorge Sabbaga, Evandro de Azambuja, Alain Hendlisz, David Queiroz Borges Muniz, Rafael Caparica, Rodrigo Canellas, Paulo P. Amaral, Larissa Costa Amorim, Elias Abdo Filho, Daniel Fernandes Saragiotto, Lucas Fernando Uratani, Milena Mak
Publikováno v:
BMJ supportivepalliative care.
ObjectivesAlthough systemic chemotherapy is often administered to patients with malignant bowel obstruction (MBO), its benefit remains unknown. This study assessed the outcomes of patients who received systemic chemotherapy as part of MBO treatment.M
Autor:
Haniel alves Araujo, Veridiana Pires de Camargo, Maria del Pilar Esteves Diz, Gilberto de Castro, Maria Ignez Braghiroli, Ingrid Barbosa, Milena Perez Mak, Oddone Freitas Melro Braghiroli, Paulo M. Hoff, Ricardo Dahmer Tiecher, Camila Motta Venchiarutti Moniz, Priscila Muniz Moraes, Lucas Fernando Uratani
Publikováno v:
Journal of Clinical Oncology. 39:2652-2652
2652 Background: Gut microbiome dysbiosis impairs systemic immune responses and recent evidence suggests its critical role in patients (pts) treated with immune checkpoint inhibitors (ICI). Proton pump inhibitors (PPI) and antibiotics (ATB) may alter
Autor:
Felipe Augusto Santiago de Almeida, Karina Costa Maia Vianna, Bianca Ramos Ferronatto, Lucas Fernando Uratani, José Zanis Neto, Sérgio Lunardon Padilha
Publikováno v:
Revista Brasileira de Cancerologia, Vol 58, Iss 1 (2012)
Introdução: Tumores estromais gastrointestinais (GIST) são neoplasias raras que se originam das células intersticiais de Cajal. Objetivo: Descrever a experiência do Hospital de Clínicas de Curitiba no tratamento do GIST localizado e avançado,
Autor:
Bruno Guilherme Zampiri De Pieri, Lucas Fernando Uratani, Iwan Augusto Collaço, Adonis Nasr, Selen Socrepa Malutta
Publikováno v:
Panamerican Journal of Trauma, Critical Care & Emergency Surgery. 1:110-112
RESUMO Objetivo Estabelecer o perfi l epidemiológico do paciente que chega ao Hospital do Trabalhador pelo resgate aéreo. Métodos Estudo observacional retrospectivo por análise de dados secundários. Separamos 50 prontuários de pacientes que che